Shanghai Pharmaceutical plans to acquire Cardinal Health China business from US-based healthcare company Cardinal Health for $1.2bn.

The divestiture will enable the Chinese pharmaceutical company to strengthen its distribution network.

Sapphire I (HK) Holdings has acquired a 49% stake in Chinese pharmaceutical company Hisun-Pfizer Pharmaceuticals from Pfizer.

The divestment enables both Hisun and Pfizer to concentrate on their core businesses.

“Sapphire I (HK) Holdings has acquired a 49% stake in Chinese pharmaceutical company Hisun-Pfizer Pharmaceuticals from Pfizer.”

Sumitomo Corporation of America (SCA) plans to acquire a 20% stake in US-based generic drug manufacturer Sawai America Inc (SAI) from Sawai Pharmaceutical (SPCL) for $211m.

SCA, a subsidiary of Sumitomo Corporation, is a transport and logistics services provider, while SPCL is a generic pharmaceuticals manufacturer.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Both companies involved in the acquisition are based in Japan.

Grupo Biotoscana SL has acquired pharmaceutical manufacturer Laboratorio DOSA S.A. for BRL100m ($30.48m).

The acquisition will enable the specialist therapeutic products developer to expand its product portfolio and geographic reach.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now